Key facts
- Notable investors include Hunan Lushan Technology Investment.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Zhimei Kangyuan
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhimei Kangyuan are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhimei Kangyuan
Manufacturer of biomedical filtration systems intended for clinical purification applications. The company integrates nanotechnology-based materials with precision-engineered membranes and device components, enabling healthcare providers to perform targeted blood purification treatments for conditions such as kidney failure, liver failure, and sepsis, with enhanced efficiency, biocompatibility, and reliability across diverse clinical environments
- Sector
- Healthcare
- HQ
- Changsha, China
- Founded
- 2024
- Ownership
- Privately Held (backing)
Zhimei Kangyuan doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhimei Kangyuan shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhimei Kangyuan in its N-PORT filings yet. We sweep new filings monthly.